Eternygen
is a contract research organization that offers clinical trial and consulting services to the pharmaceutical and biotechnology industries... Read moreEternygen
is a contract research organization that offers clinical trial and consulting services to the pharmaceutical and biotechnology industries... Read more
News
Oct 26, 2020
MarketScreener
Eternygen GmbH: Eternygen GmbH : Announces the First Closing of its Series A2 Funding Round
Feb 10, 2020
centralcharts
Press Release: Eternygen : DGAP-News: Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH
Oct 04, 2018
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Sep 10, 2018
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 23, 2018
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250
Sep 02, 2017
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23082017 Prices from USD $250
May 08, 2017
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 25042017 Prices from USD $250
Mar 29, 2017
BioPortfolio
Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23032017 Prices from USD $250
Jan 10, 2017
Contract Pharma
Eternygen: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
Jan 08, 2017
manufacturingchemist
Eternygen: Eternygen GmbH closes €8.0 million series A financing led by Epidarex Capital.
